Marketed in 33 countries across much of the European Economic Area and parts of Oceania, Cortavance is a corticosteroid preparation built around hydrocortisone, one of the longest-established glucocorticoid molecules in clinical use. The brand sits within a family of dermatological and systemic corticosteroid products that travellers and expatriates encounter regularly, often under different names from one country to the next.
Cortavance is used across a broad set of indications drawn from the corticosteroid therapeutic field, including inflammatory skin conditions such as dermatitis and psoriasis, allergic and anti-inflammatory uses, and adjunctive roles in conditions like asthma, pemphigus, and certain oncology and chemotherapy supportive contexts. The complete registered indication list, together with the full set of pharmacological categories the product belongs to, appears in the structured data block further down this page.
Because hydrocortisone is one of the most internationally distributed corticosteroid molecules, a reader who has been prescribed Cortavance in one country and is travelling or relocating will usually find a hydrocortisone-containing product in the destination market — sometimes as Cortavance, often under another brand name. Representative markets where Cortavance is registered include France, Australia, Germany, Hungary, and Iceland, but regulatory status, formulation, and whether the product is dispensed over the counter or by prescription differ meaningfully between jurisdictions.
Other medications in the broader corticosteroid class are also widely sold internationally under various molecules and brand names, and the appropriate equivalent depends on the indication being treated rather than on the brand alone. A local pharmacist is well placed to identify regionally available hydrocortisone products. Decisions about starting Cortavance, switching from it, or substituting another corticosteroid should be made together with a healthcare provider familiar with the patient's situation.
